第一作者:
Heng-Wei,Hsu
第一单位:
Department of Pharmacology, Loma Linda University, Loma Linda, CA, USA; Department of Basic Sciences, Loma Linda University, Loma Linda, CA, USA; LLU Cancer Center Biospecimen Laboratory, Loma Linda University, Loma Linda, CA, USA.
作者:
关键词
5-fluorouracil, hydroxyurea, radiotherapyAAAKTAntiangiogenesisCACCRTCICOXComibination therapyDNA damageEBVEGF/RERCCEpstein-Barr virusFGFFHXFLKFLTGLUTHIFHNSCCHPVHead and neck cancerIFPIGRTIMRTKDRKitMAPKMMPNPCOSRPDGF/RPFRPI3KPLGFRTRadiationSTATTKITargeted therapyVEGF/RVEGFR/PDGFR inhibitorX-ray repair cross-complementing proteinXRCCantiangiogenic agentcarbonic anhydraseconcurrent chemoradiationconfidence intervalcyclooxygenaseepidermal growth factor/receptorexcision-repair cross-complementing proteinfetal liver kinasefibroblast growth factorfms-like tyrosine kinaseglucose transporterhead and neck squamous cell carcinomahuman papilloma virushypofractionated image-guided radiotherapyhypoxia-inducing factorintensity modulated radiotherapyinterstitial fluid pressurekinase insert domain receptormTORmammalian target of rapamycinmatrix metalloproteinasemitogen-activated protein kinasenasopharyngeal carcinomaoverall survival ratephosphoinositide 3-kinaseplacenta growth factorplatelet-derived growth factor/receptorprogression free rateprotein kinase Bradiationsignal transducer and activator of transcriptionstem cell factor receptortyrosine kinase inhibitorvascular endothelial growth factor/receptor
医学主题词
血管生成抑制剂(Angiogenesis Inhibitors);癌, 鳞状细胞(Carcinoma, Squamous Cell);综合疗法(Combined Modality Therapy);头颈部肿瘤(Head and Neck Neoplasms);人类(Humans)
DOI
10.1016/j.oraloncology.2013.10.003
PMID
24269532
发布时间
2013-12-16
- 浏览100
Oral oncology
19-26页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



